Millennium Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Millennium Management’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-80,000	Closed	-$4.49M	–	4042
2017 Q2	$4.49M	Hold	80,000	–	–	0.01%	1578
2017 Q1	$3.13M	Buy	80,000 +55,000	+220%	+$1.75M	0.01%	1736
2016 Q4	$561K	Sell	25,000 -57,500	-70%	-$1.12M	﹤0.01%	2628
2016 Q3	$1.87M	Buy	+82,500	New	+$1.94M	﹤0.01%	1966
2016 Q2	–	Sell	-305,000	Closed	-$6.22M	–	3766
2016 Q1	$6.22M	Buy	+305,000	New	+$9.68M	0.02%	1126

Millennium Management's PTLA Position: Q3 2020 in Review

Millennium Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 683,381 shares — an estimated $12.3M sold.

Millennium Management first reported a position in PTLA in Q2 2013 and held it in 27 quarters. The position peaked at $84.8M in Q4 2015. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

Millennium Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Millennium Management sold 683,381 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $12.3M.
Millennium Management first reported a position in Portola Pharmaceuticals, Inc. in Q2 2013 and held it in 27 quarters.
Millennium Management's Portola Pharmaceuticals, Inc. position peaked at $84.8M in Q4 2015.
0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Millennium Management's 13F filing for Q3 2020, filed 16 Nov 2020.